
Dou YongchongProfessor, Chief Physician, Master's Supervisor
Academic Leader of the Oncology Center, Shenzhen Huaqiao Hospital
Vice Chairman of Shenzhen Anti-Cancer Association
Honorary Chairman of the Interventional Medicine Branch, Shenzhen Medical Association
Former Director of the Interventional Diagnosis and Treatment Department/Academic Leader, Shenzhen People's Hospital
Chairman of the Tumor Interventional Diagnosis and Treatment Committee, Shenzhen Anti-Cancer Association
Vice Chairman of the Interventional Physicians Committee, Guangdong Medical Doctor Association
Standing Member of the Chinese Society of Clinical Oncology
Standing Member of the Tumor Interventional Treatment Committee of Chinacommittee member.
Standing Member of the Chinese Radioactive Seed Treatment Committee
Honorary Chairman of the Tumor Hyperthermia Committee, Shenzhen Anti-Cancer Association
Standing Member of the Asian Cryotherapy Association
Director of the Asian Cryotherapy Training Base
Expert Profile: Engaged in interventional radiology for40years. Graduated from the Medical Department of Tongji Medical University and was assigned to the Radiology Department of Tongji Hospital.1990In ..., was recruited as a key professional to Shenzhen People’s Hospital, where he took the lead in establishing the largest interventional radiology department in the Shenzhen area, filling the gap in this field. He served as the academic leader of this field in Shenzhen and at Shenzhen People’s Hospital. He is currentlyAcademic Leader of the Oncology Center, Shenzhen Huaqiao Hospital, stationed at the hospital on a long-term basis to guide the discipline development of the tumor center.
Professional Expertise: 1983In ..., he was among the first in China to carry out interventional radiology treatments.1996In ..., he completed South China’s first intracranial and carotid artery stent placement.2000In ..., he was the first in South China to perform endovascular exclusion for abdominal aortic aneurysm and portal hypertensionTIPS(portosystemic shunt procedures,)as well as tumor radiofrequency ablation, argon-helium cryoablation, and iodine-125125radioactive seed implantation. He is skilled in interventional minimally invasive treatment of various benignmalignant tumorand malignant tumors, as well as peripheral vascular interventional minimally invasive treatment. Patients from across China,(including Guangdong Province, the three northeastern provinces, Hubei, Shanxi, Sichuan, Zhejiang, and Guizhou,)as well as overseas Chinese and compatriots from Hong Kong and Macau, have come to Shenzhen seeking his treatment. He has trained multiple batches of medical personnel from mainland China, Taiwan, Hong Kong, and Malaysia in argon-helium cryoablation therapy.
Academic achievements: Published dozens of academic papers and completed multiple municipal-level and hospital-level research projects. He has received numerous hospital-level awards,/as well as various grants and awards from the Shenzhen Science and Technology Bureau and the Provincial Science and Technology Department. He has participated in international and domestic conferences and delivered special lectures on multiple occasions. He was awarded the"2015‘Top Ten Outstanding Medical Professionals in Hainan’ in ...,"and the honor of;2019, was honored with the title ofWenchang City’s"‘Coconut Town Migratory Bird Talent.’"He has successfully performed many high-difficulty minimally invasive interventional surgeries on multiple occasions, relieving suffering for numerous cancer patients and helping them regain confidence in overcoming their illness. He is deeply praised and trusted by patients and their families. He has completed thousands of minimally invasive procedures including interventional therapy and radiofrequency ablation, with zero failures. He has launched numerous new technologies and projects, many of which filled gaps in Shenzhen and the province.
As a leading figure in China’s minimally invasive interventional oncology discipline,Dou Yongchongthe professor has led his team in continuously overcoming technical challenges while emphasizing the introduction of new domestic and international technologies and pioneering new technological innovations. Using interventional and radiofrequency therapy, primarily targeting the tumor lesion for in cancer mortalityprecise in cancer mortalitylocalization, injection, blockade treatment, control and elimination of cancer cells, and ablation for tumor shrinkage, without affecting other normal cells. This approach is characterized by minimal trauma, virtually no toxic side effects, and minimal patient discomfort, demonstrating outstanding therapeutic efficacy.Dou YongchongWith superb medical skills, this doctor has provided a lifeline for patients with mid-to-late stage cancer, and is known as"‘the guardian angel of cancer patients’ lives,’"and has become an in cancer mortalityoutstanding expert in the field of interventional radiology in Shenzhen.
Major media outlets including People’s Daily, Xinhua Net, China Daily, Guangzhou Daily, Southern Metropolis Daily, Yangcheng Evening News, Phoenix News, Xinhua Daily, and Information Times have all conducted extensive coverage.




